Articles

1. Validation of cardiac image-derived input functions for functional PET quantification

   • Murray Bruce Reed
   • Patricia Anna Handschuh
   • Andreas Hahn

   Original Article Open access 27 April 2024

   

2. Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?

   • Janke Kleynhans
   • Thomas Ebenhan
   • Mike Machaba Sathekge

   Review Article Open access 27 April 2024

   

3. EANM consensus document on the use of [¹⁸F]FDG PET/CT in fever and inflammation of unknown origin

   • Søren Hess
   • Edel Noriega-Álvarez
   • Olivier Gheysens

   Original Article Open access 27 April 2024

   

4. Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”

   • David Kersting
   • Silvia Morbelli
   • Hein J. Verberne

   Correction Open access 25 April 2024

5. Comparison of novel PSMA-targeting [¹⁷⁷Lu]Lu-P17-087 with its albumin binding derivative [¹⁷⁷Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study

   • Linlin Li
   • Jiarou Wang
   • Zhaohui Zhu

   Original Article 25 April 2024

   

6. Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?”

   • An-Li Yu
   • Cheng-Hsuan Tsai
   • Yen-Hung Lin

   Letter to the Editor 24 April 2024

7. How nuclear imaging changed parathyroid surgical strategies through time

   • H. M. Schouw
   • M. E. Noltes
   • S. Kruijff

   Editorial 23 April 2024

   

8. Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging

   • Yaqi Tian
   • Hongliang Shen
   • Jie Tian

   Original Article 22 April 2024

   

9. Synthesis and preclinical evaluation of novel ¹⁸F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography

   • G. B. Spoelstra
   • S. N. Blok
   • P. H. Elsinga

   Original Article Open access 22 April 2024

   

10. Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers

    • Rajiv Ranjit Nair
    • Aprameya Prasad
    • Stavroula Sofou

    Original Article 20 April 2024

    

11. The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions

    • Adeline Zinsz
    • Celso Pouget
    • Antoine Verger

    Original Article 19 April 2024

    

12. B-Glycine as a marker for β cell imaging and β cell mass evaluation

    • Yuxiang Han
    • Hui Liu
    • Zhibo Liu

    Original Article 18 April 2024

    

13. Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [¹⁷⁷Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer

    • Hong Song
    • Maria Isabel Leonio
    • Andrei Iagaru

    Original Article 18 April 2024

    

14. Cadherin-17 as a target for the immunoPET of adenocarcinoma

    • Samantha Delaney
    • Outi Keinänen
    • Brian M. Zeglis

    Original Article Open access 16 April 2024

    

15. Intraoperative image-guidance during robotic surgery: is there clinical evidence of enhanced patient outcomes?

    • Stefano Tappero
    • Giuseppe Fallara
    • Paolo Dell’Oglio

    Review Article 12 April 2024

    

16. Visual extended reality tools in image-guided surgery in urology: a systematic review

    • Enrico Checcucci
    • Alberto Piana
    • Francesco Porpiglia

    Review Article 09 April 2024

    

17. Artificial intelligence-based application in multiple myeloma

    • Leandra Piscopo
    • Mariano Scaglione
    • Michele Klain

    Editorial 08 April 2024

18. PET/CT study of dopamine transporter (DAT) binding with the triple reuptake inhibitor toludesvenlafaxine in rats and humans

    • Zhiwei Huang
    • Junhao Wu
    • Yifeng Shen

    Original Article 08 April 2024

    

19. Clinicopathological and molecular predictors of [¹⁸F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial

    • Antonio Llombart-Cussac
    • Aleix Prat
    • Geraldine Gebhart

    Original Article Open access 08 April 2024

    

20. Targeting CXCR4/CXCL12 axis via [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂ with CXCR4 antagonist in triple-negative breast cancer

    • Guangfa Bao
    • Ziqiang Wang
    • Xiaohua Zhu

    Original Article Open access 08 April 2024

    

21. An ultra-small organic dye nanocluster for enhancing NIR-II imaging-guided surgery outcomes

    • Yajun Wang
    • Ding Zhou
    • Shoujun Zhu

    Original Article 06 April 2024

    

22. Optimizing the pharmacokinetics of an ²¹¹At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

    • Hiroaki Echigo
    • Masayuki Munekane
    • Kazuma Ogawa

    Original Article Open access 04 April 2024

    

23. Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”

    • David Kersting
    • Silvia Morbelli
    • Hein J. Verberne

    Editorial 04 April 2024

    

24. Latent phosphaturic mesenchymal tumor in left planta detected by [¹⁸F]F-AlF-NOTA-octreotide PET/CT

    • Congcong Yu
    • Lin Chen
    • Hong Zhang

    Image of the Month 03 April 2024

    

25. Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™

    • Tony Georgiev
    • Lucrezia Principi
    • Samuele Cazzamalli

    Short Communication 02 April 2024

    

26. Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence

    • Yuekai Li
    • Shiwei Wang
    • Xiang Li

    Short Communication 02 April 2024

    

27. The status of nuclear medicine in China: the first official national survey

    • Haiqiong Zhang
    • Jin Zheng
    • Li Huo

    Original Article 02 April 2024

    

28. Disrupted gut microecology after high-dose ¹³¹I therapy and radioprotective effects of arachidonic acid supplementation

    • Ganghua Lu
    • Dingwei Gao
    • Zhongwei Lv

    Original Article Open access 02 April 2024

    

29. Clinical translation of a novel FAPI dimer [⁶⁸Ga]Ga-LNC1013

    • Yue Tan
    • Jian Li
    • Jingjing Zhang

    Original Article 02 April 2024

    

30. The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica—a prospective study of 101 patients

    • Andreas Wiggers Nielsen
    • Ib Tønder Hansen
    • Kresten Krarup Keller

    Original Article Open access 02 April 2024

    

31. Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice

    • Putri Andriana
    • Ruth Fair-Mäkelä
    • Anne Roivainen

    Original Article Open access 27 March 2024

    

32. Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance

    • Chiara Lauri
    • Edel Noriega-Álvarez
    • Alberto Signore

    Original Article Open access 27 March 2024

33. Dosimetry and pharmacokinetics of [¹⁷⁷Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

    • Seval Beykan Schürrle
    • Uta Eberlein
    • Michael Lassmann

    Original Article Open access 26 March 2024

    

34. Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics

    • Laura García-Zoghby
    • Mariano Amo-Salas
    • Ana María García Vicente

    Original Article 23 March 2024

    

35. Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis

    • Zhu Li
    • Junyi Chen
    • Zhibo Liu

    Correction 22 March 2024 Pages: 1796 - 1797

    

36. The superior detection rate of total-body [⁶⁸Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [⁶⁸Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy

    • Yining Wang
    • Liang Dong
    • Ruohua Chen

    Original Article 22 March 2024

    

37. A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging

    • Xingyang Zhao
    • Guojin Zhang
    • Liming Nie

    Original Article 21 March 2024 Pages: 1593 - 1604

    

38. Image-based dosimetry for [²²⁵Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics

    • Grigory Liubchenko
    • Guido Böning
    • Astrid Delker

    Original Article Open access 21 March 2024

    

39. “Metabolic fingerprints” of cachexia in lung cancer patients

    • Armin Frille
    • Jann Arends
    • (the LuCaPET consortium)

    Letter to the Editor Open access 20 March 2024

40. Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease

    • Can Zhou
    • Fantian Zeng
    • Jian Yang

    Review Article 19 March 2024

    

41. Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1

    • Wenpeng Huang
    • Mai Hong Son
    • Weibo Cai

    Editorial 16 March 2024 Pages: 1574 - 1577

42. Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET

    • Godber Mathis Godbersen
    • Pia Falb
    • Andreas Hahn

    Original Article Open access 16 March 2024

    

43. Early detection of anthracycline-induced cardiotoxicity using [⁶⁸ Ga]Ga-FAPI-04 imaging

    • Zhuxin Wei
    • Hongchuang Xu
    • Shihua Zhao

    Original Article 16 March 2024

    

44. Radiofrequency ablation versus radioactive iodine: the race for the best cure

    • Fabio Volpe
    • Carmela Nappi
    • Michele Klain

    Editorial 15 March 2024

45. Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers

    • Luca Sofia
    • Federico Massa
    • Silvia Morbelli

    Image of the Month Open access 14 March 2024

    

46. ImmunoPET/CT imaging of clear cell renal cell carcinoma with [¹⁸F]RCCB6: a first-in-human study

    • Qianyun Wu
    • Yanfei Wu
    • Weijun Wei

    Original Article 14 March 2024

    

47. [¹⁷⁷Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study

    • Swayamjeet Satapathy
    • Madhav Prasad Yadav
    • Chandrasekhar Bal

    Original Article 12 March 2024

    

48. [¹⁸F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy

    • Jinbo Gui
    • Mengting Li
    • Xiaoli Lan

    Original Article 12 March 2024

    

49. PET imaging of PD-L1 with a small molecule radiotracer

    • Yajie Zhao
    • Jessica C. Hsu
    • Weibo Cai

    Editorial 09 March 2024 Pages: 1578 - 1581

50. [⁶⁸Ga]Ga-FAPI versus [¹⁸F]FDG PET/CT in the evaluation of Langerhans cell histiocytosis

    • Linlin Guo
    • Guohua Shen

    Image of the Month 09 March 2024